| abstract |
The present invention relates to the cloning, expression and isolation of recombinant forms of β-amyloid protein containing an N-terminal methionine (or one or more other amino acid residues), the production of therapeutic antibodies, and therapeutic small molecules. And the use of this recombinant protein in the performance of diagnostic assays. |